These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 23956997)

  • 1. Protein homeostasis defects of alanine-glyoxylate aminotransferase: new therapeutic strategies in primary hyperoxaluria type I.
    Pey AL; Albert A; Salido E
    Biomed Res Int; 2013; 2013():687658. PubMed ID: 23956997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase.
    Oppici E; Roncador A; Montioli R; Bianconi S; Cellini B
    Biochim Biophys Acta; 2013 Dec; 1832(12):2277-88. PubMed ID: 24055001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver peroxisomal alanine:glyoxylate aminotransferase and the effects of mutations associated with Primary Hyperoxaluria Type I: An overview.
    Oppici E; Montioli R; Cellini B
    Biochim Biophys Acta; 2015 Sep; 1854(9):1212-9. PubMed ID: 25620715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of the S187F variant of human liver alanine: glyoxylate [corrected] aminotransferase associated with primary hyperoxaluria type I and its functional implications.
    Oppici E; Fodor K; Paiardini A; Williams C; Voltattorni CB; Wilmanns M; Cellini B
    Proteins; 2013 Aug; 81(8):1457-65. PubMed ID: 23589421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cycloserine enantiomers are reversible inhibitors of human alanine:glyoxylate aminotransferase: implications for Primary Hyperoxaluria type 1.
    Dindo M; Grottelli S; Annunziato G; Giardina G; Pieroni M; Pampalone G; Faccini A; Cutruzzolà F; Laurino P; Costantino G; Cellini B
    Biochem J; 2019 Dec; 476(24):3751-3768. PubMed ID: 31794008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular requirements for peroxisomal targeting of alanine-glyoxylate aminotransferase as an essential determinant in primary hyperoxaluria type 1.
    Fodor K; Wolf J; Erdmann R; Schliebs W; Wilmanns M
    PLoS Biol; 2012; 10(4):e1001309. PubMed ID: 22529745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between the molecular effects of mutations at the dimer interface of alanine-glyoxylate aminotransferase leading to primary hyperoxaluria type I and the cellular response to vitamin B
    Dindo M; Oppici E; Dell'Orco D; Montone R; Cellini B
    J Inherit Metab Dis; 2018 Mar; 41(2):263-275. PubMed ID: 29110180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular insights into primary hyperoxaluria type 1 pathogenesis.
    Cellini B; Oppici E; Paiardini A; Montioli R
    Front Biosci (Landmark Ed); 2012 Jan; 17(2):621-34. PubMed ID: 22201765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Chaperoning Activity of Amino-oxyacetic Acid on Folding-Defective Variants of Human Alanine:Glyoxylate Aminotransferase Causing Primary Hyperoxaluria Type I.
    Oppici E; Montioli R; Dindo M; Maccari L; Porcari V; Lorenzetto A; Chellini S; Voltattorni CB; Cellini B
    ACS Chem Biol; 2015 Oct; 10(10):2227-36. PubMed ID: 26161999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folding Defects Leading to Primary Hyperoxaluria.
    Oppici E; Dindo M; Conter C; Borri Voltattorni C; Cellini B
    Handb Exp Pharmacol; 2018; 245():313-343. PubMed ID: 29071511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary hyperoxalurias: disorders of glyoxylate detoxification.
    Salido E; Pey AL; Rodriguez R; Lorenzo V
    Biochim Biophys Acta; 2012 Sep; 1822(9):1453-64. PubMed ID: 22446032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyridoxamine and pyridoxal are more effective than pyridoxine in rescuing folding-defective variants of human alanine:glyoxylate aminotransferase causing primary hyperoxaluria type I.
    Oppici E; Fargue S; Reid ES; Mills PB; Clayton PT; Danpure CJ; Cellini B
    Hum Mol Genet; 2015 Oct; 24(19):5500-11. PubMed ID: 26199318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with primary hyperoxaluria type I.
    Oppici E; Montioli R; Lorenzetto A; Bianconi S; Borri Voltattorni C; Cellini B
    Mol Genet Metab; 2012 Jan; 105(1):132-40. PubMed ID: 22018727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of human alanine:glyoxylate aminotransferase in Escherichia coli: renaturation from guanidine-HCl and affinity for pyridoxal phosphate co-factor.
    Coulter-Mackie MB; Lian Q; Wong SG
    Protein Expr Purif; 2005 May; 41(1):18-26. PubMed ID: 15802217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misfolding caused by the pathogenic mutation G47R on the minor allele of alanine:glyoxylate aminotransferase and chaperoning activity of pyridoxine.
    Montioli R; Oppici E; Dindo M; Roncador A; Gotte G; Cellini B; Borri Voltattorni C
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1280-9. PubMed ID: 26149463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural and Unnatural Compounds Rescue Folding Defects of Human Alanine: Glyoxylate Aminotransferase Leading to Primary Hyperoxaluria Type I.
    Oppici E; Montioli R; Dindo M; Cellini B
    Curr Drug Targets; 2016; 17(13):1482-91. PubMed ID: 26931357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human wild-type alanine:glyoxylate aminotransferase and its naturally occurring G82E variant: functional properties and physiological implications.
    Cellini B; Bertoldi M; Montioli R; Paiardini A; Borri Voltattorni C
    Biochem J; 2007 Nov; 408(1):39-50. PubMed ID: 17696873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allele-specific characterization of alanine: glyoxylate aminotransferase variants associated with primary hyperoxaluria.
    Lage MD; Pittman AM; Roncador A; Cellini B; Tucker CL
    PLoS One; 2014; 9(4):e94338. PubMed ID: 24718375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A glycine-to-glutamate substitution abolishes alanine:glyoxylate aminotransferase catalytic activity in a subset of patients with primary hyperoxaluria type 1.
    Purdue PE; Lumb MJ; Allsop J; Minatogawa Y; Danpure CJ
    Genomics; 1992 May; 13(1):215-8. PubMed ID: 1349575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional synergism between the most common polymorphism in human alanine:glyoxylate aminotransferase and four of the most common disease-causing mutations.
    Lumb MJ; Danpure CJ
    J Biol Chem; 2000 Nov; 275(46):36415-22. PubMed ID: 10960483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.